AFMD
Affimed NV
NASDAQ: AFMD · HEALTHCARE · BIOTECHNOLOGY
$0.18
+0.00% today
Updated 2026-04-29
Market cap
$2.98M
P/E ratio
—
P/S ratio
0.53x
EPS (TTM)
$-5.09
Dividend yield
—
52W range
$0 – $1
Volume
23.5M
Affimed NV (AFMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-8,709.00%
ROE
-149.50%
ROA
-49.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $1.17M | $-14.31M | 100.00% | -886.36% | -1,220.29% |
| 2013 | $5.09M | $-26.10M | 100.00% | -308.69% | -513.05% |
| 2014 | $3.38M | $-259000.00 | 100.00% | -241.81% | -7.66% |
| 2015 | $7.56M | $-20.24M | 100.00% | -282.24% | -267.64% |
| 2016 | $6.31M | $-32.22M | 100.00% | -507.51% | -510.23% |
| 2017 | $2.01M | $-30.22M | 100.00% | -1,356.22% | -1,503.63% |
| 2018 | $23.73M | $-19.48M | 100.00% | -82.31% | -82.06% |
| 2019 | $21.39M | $-32.37M | 100.00% | -151.35% | -151.30% |
| 2020 | $28.36M | $-41.37M | 100.00% | -122.42% | -145.86% |
| 2021 | $40.37M | $-57.52M | 100.00% | -158.62% | -142.50% |
| 2022 | $41.35M | $-86.00M | 100.00% | -213.09% | -207.98% |
| 2023 | $8.28M | $-105.94M | 100.00% | -1,288.95% | -1,280.22% |